CARB-X Releases 2024 Annual Report Celebrating a Year of Progress
Kevin Outterson is quoted.
April 30, 2025 CARB-XAntimicrobial Resistance: Q&A with Carb-X About the Fight Against AMR
Kevin Outterson is interviewed.
April 15, 2025 European Biotechnology Life and Science Industry MagazineCharting the Path to Tackle Amr: How to Create an Inclusive and Impactful Independent Panel
Kevin Outterson pens an opinion.
January 22, 2025 Center For Global DevelopmentThe Superbug Fight Needs a Better Business Model
Kevin Outterson is quoted.
November 19, 2024 Global Health NowAs World’s Health Ministers Meet in Jeddah: Calls for Strong Amr Science Panel with Authority to ‘Challenge’ Sponsors
Kevin Outterson is quoted.
November 14, 2024 Health Policy WatchA Pathogen’s Plight: The International Lethal Pandemic of Antibiotic-Resistant Bacteria
Kevin Outterson is quoted.
November 14, 2024 Glimpse From the GlobeAntimicrobial Resistance Italian Government Gives $21 Million to BU-Led Effort to Develop New Antibiotics, Vaccines, Diagnostics
Kevin Outterson is interviewed.
October 22, 2024 Boston UniversityWhat Happens When the Last AMR Researcher Turns Off the Lights in the Lab?
Kevin Outterson is quoted.
August 21, 2024 Infectious Disease Special EditionHouse Budget Committee Examines Budgetary Effects of Antimicrobial Resistance and the Broken Antibiotic Development Pipeline
Kevin Outterson is mentioned.
July 25, 2024 US House Budget Committee4.95 Million People Die from Treatable Infections Annually. A New Project Tells Their Stories
Kevin Outterson is featured.
May 7, 2024 Forbes